How to assess kidney function in oncology patients.

Area of Science:

• Nephrology
• Oncology
• Pharmacology

Background:

• Kidney function assessment is vital for cancer patient survival risk, drug dosing, and clinical trial eligibility.
• Inaccurate kidney function estimation can lead to suboptimal treatment, toxicity, or treatment failure.
• Current methods for evaluating kidney function in oncology require further investigation for various cancer therapies.

Purpose of the Study:

• To highlight the importance of accurate kidney function assessment in oncology.
• To discuss the limitations of current estimation formulas for glomerular filtration rate and creatinine clearance.
• To emphasize the need for comprehensive kidney function evaluation beyond filtration rate, including tubular and vascular aspects.

Main Methods:

• Review of current practices in kidney function assessment for oncology patients.
• Discussion of the impact of overestimation and underestimation of kidney function on treatment outcomes.
• Exploration of the role of urinalysis and kidney imaging in therapeutic decision-making.
• Consideration of novel technologies like kidney-on-a-chip systems.

Main Results:

• Current formulas for estimating kidney function may not be universally applicable to all cancer patients and therapies.
• Over/underestimation of kidney function can significantly impact chemotherapy efficacy and patient safety.
• Comprehensive assessment involving filtration, tubular, and vascular parameters is necessary.
• New technologies show promise but require further validation for clinical use in oncology.

Conclusions:

• Accurate kidney function assessment is fundamental for personalized cancer treatment and improved patient outcomes.
• There is a critical need for validated methods to assess kidney function in the context of evolving cancer therapies.
• Integrating advanced diagnostic tools and considering broader aspects of kidney health are essential for managing oncology patients.